Kijimea IBS

Active ingredient

Wirkstoff Bifidobakterien B. bifidum MIMBb75

The active ingredient of Kijimea IBS is the unique and patented bifidobacteria strain B. bifidum MIMBb75.
This is the only bacteria strain in the world that has been clinically proven to significantly reduce irritable bowel syndrome (IBS) and its symptoms and to simultaneously improve patients’ quality of life.

Mode of action

Gestörte Darmbarriere als Ursache für das Reizdarmsyndrom

Today, scientists are increasingly convinced that IBS is caused by a damaged intestinal barrier. It is thought that pollutants and pathogens penetrate the damaged intestinal barrier and enter the intestinal wall where they cause the typical IBS symptoms. Affected people repeatedly suffer from constipation or diarrhoea, flatulence or abdominal cramps.
Kijimea IBS fights these symptoms by tackling the cause of the irritated bowel: it attaches itself directly to the damaged intestinal wall like a plaster to a wound.

The plaster for the irritated bowel

Product information
Kijimea IBS is a Class IIb licensed medical device for the treatment of IBS with its typical symptoms constipation, diarrhoea, abdominal pain, flatulence and bloating. There are no known side effects or interactions with other drugs.

Kijimea IBS capsules contain neither preservatives, sweeteners, flavourings, lactose nor gluten and are also ideally suited for patients with diabetes.

IBS test

Take the IBS test now and find out whether you have indications of IBS.

Food diary

Download our free food diary and find out which foods and which circumstances might contribute to your digestive problems.

Frequently Asked Questions

Do you have any questions regarding Kijimea IBS? Check below for answers to frequently asked questions about this product.